BOTHELL, Wash.--(BUSINESS WIRE)--Acucela, a clinical-stage biotechnology company focused on developing new treatments for blinding eye diseases, announced today the appointment of Glen Y. Sato, a partner in the Life Sciences and Corporate practice groups of the law firm Cooley Godward Kronish LLP, to its Board of Directors.
